TY - JOUR
T1 - Single Incision Robotic Cystectomy and Hybrid Orthotopic Neobladder Reconstruction
T2 - A Step by Step Description
AU - Tyson, Mark
AU - Andrews, Paul
AU - Cheney, Scott
AU - Humphreys, Mitchell
N1 - Funding Information:
This study was also generously supported by funding from the Robert D. and Patricia E. Kern Center for Health Care Delivery Science, the Christian Haub Family Career Development Award for Cancer Research Honoring Dr Richard Emslander, and the Eric and Gail Blodgett Foundation. We would like to recognize and thank Kathy Morgan, PAC and Kathryn Cleland, PAC for assisting during surgery and Nick Carducci and Mikayla King from Intuitive for their critical review of this manuscript. We also thank Dr. Ronney Abaza and Dr. Johnny Yi for their helpful advice during our first few cases.
Funding Information:
Financial Disclosure: This publication was supported by Grant Number P30 CA015083 from the National Cancer Institute (NCI). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NIH.
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/10
Y1 - 2021/10
N2 - Objective: To describe a new technique for single incision robotic cystectomy and Studer-type ileal neobladder using the single-port (SP) da Vinci SP robotic platform. Methods: In April 2021, a 71 year-old patient underwent a single incision robotic cystectomy and orthotopic Studer-type ileal neobladder using the single-port da Vinci SP robotic platform for cT2, cN0 urothelial carcinoma of the bladder. He was not a candidate for neoadjuvant cisplatin-based combination chemotherapy and declined participation in a clinical trial. Results: Total operative time was 554 minutes and estimated blood loss was 250 cc. He was discharged on postoperative day six without developing any Clavien complications. He underwent adjuvant chemotherapy for node-positive disease and follow-up through June 2021 was notable for the absence of any significant complications or readmissions. We provide a comprehensive discussion of the required instrumentation, a description of the technique with illustrations, and discuss the advantages and disadvantages of this technology as it pertains to cystectomy and urinary diversion. Conclusion: We make no claim regarding the superiority of this technique over others, only that it is technically feasible and that the approach holds promise.
AB - Objective: To describe a new technique for single incision robotic cystectomy and Studer-type ileal neobladder using the single-port (SP) da Vinci SP robotic platform. Methods: In April 2021, a 71 year-old patient underwent a single incision robotic cystectomy and orthotopic Studer-type ileal neobladder using the single-port da Vinci SP robotic platform for cT2, cN0 urothelial carcinoma of the bladder. He was not a candidate for neoadjuvant cisplatin-based combination chemotherapy and declined participation in a clinical trial. Results: Total operative time was 554 minutes and estimated blood loss was 250 cc. He was discharged on postoperative day six without developing any Clavien complications. He underwent adjuvant chemotherapy for node-positive disease and follow-up through June 2021 was notable for the absence of any significant complications or readmissions. We provide a comprehensive discussion of the required instrumentation, a description of the technique with illustrations, and discuss the advantages and disadvantages of this technology as it pertains to cystectomy and urinary diversion. Conclusion: We make no claim regarding the superiority of this technique over others, only that it is technically feasible and that the approach holds promise.
UR - http://www.scopus.com/inward/record.url?scp=85111709968&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111709968&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2021.06.033
DO - 10.1016/j.urology.2021.06.033
M3 - Article
C2 - 34274390
AN - SCOPUS:85111709968
VL - 156
SP - 285
EP - 288
JO - Urology
JF - Urology
SN - 0090-4295
ER -